GSK Jan 2025 45.000 call
| Previous close | 0.6000 |
| Open | 0.6000 |
| Bid | 0.5000 |
| Ask | 0.6500 |
| Strike | 45.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.6000 - 0.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 677 |
- Yahoo Finance Video
FTC warns pharma companies on excessive drug patenting
The Federal Trade Commission (FTC) issued warning letters to several pharmaceutical companies, including AbbVie (ABBV) AstraZeneca (AZN), and Teva (TEVA), over excessive patenting of medications as Medicare negotiates drug costs with the pharma industry. Yahoo Finance Health Reporter Anjalee Khemlani explains the Biden administration's ideas to license patents to lower drug costs for patients. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Insider Monkey20 Countries with Free Health Care
In this article, we will be taking a look at the 20 countries with free health care. To skip our detailed analysis, you can go directly to see the 5 countries with free health care. The U.S. is one of the only advanced countries in the world to not have free healthcare, which is said […]
ZacksGlaxo (GSK) Upgraded to Buy: What Does It Mean for the Stock?
Glaxo (GSK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
